Skip to Content

Efavirenz / Emtricitabine / Tenofovir disoproxil Mylan

Shortage
Licence status
Authorised: 05/09/2017
Active substances
Efavirenz, Tenofovir disoproxil maleate, Emtricitabine
Dosage Form
Film-coated tablet
Licence number
EU/1/17/1222/001-002
Licence holder
Mylan Pharmaceuticals Limited

Licence information

ATC code
J05AR Antivirals for treatment of HIV infections, combinations, J05AR06 emtricitabine, tenofovir disoproxil and efavirenz
Route of supply
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
05/09/2017

Stay updated: document advice

The information and documents on this page are subject to frequent updates. We recommend you do not retain saved or printed versions of them. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie